Stay updated on OpACIN-neo Optimal Combo Trial
Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.

Latest updates to the OpACIN-neo Optimal Combo Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedLocations section now includes New South Wales (Australia) and North Holland (Netherlands) as study sites. The footer HHS Vulnerability Disclosure link was removed and the page revision was updated to v3.3.3.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded status history and sponsor details to the study page, including 'Last known status was:', 'The Netherlands Cancer Institute', date '2023-11', and 'Verified'.SummaryDifference0.3%

- Check39 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed, and a new revision tag v3.3.2 was added. The previous PubMed sourcing statement and v3.2.0 tag were removed.SummaryDifference0.1%

- Check46 days agoChange DetectedThe top funding/operating status notice at the page has been removed. This does not affect the trial details, eligibility criteria, or locations.SummaryDifference0.3%

- Check60 days agoChange DetectedThe changes appear to be minor UI/layout adjustments and do not show edits to core trial information such as status, outcomes, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to OpACIN-neo Optimal Combo Trial
Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.